Xcout Intel
Sensei Biotherapeutics, Inc.
Sensei Biotherapeutics, Inc. is a clinical stage biotechnology company focused on the discovery and development of new therapies.
Subscribe to see Sensei Biotherapeutics, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Sensei Biotherapeutics, Inc. at a glance
Sensei Biotherapeutics, Inc. is a biotech company headquartered in United States. It is publicly listed (SNSE) with a market capitalisation of $18.6M. Xcout tracks 14 named people at Sensei Biotherapeutics, Inc., including Christopher Gerry (President, General Counsel, Secretary & Director). Xcout recorded 16 job postings from Sensei Biotherapeutics, Inc. in the last 90 days.
Sensei Biotherapeutics, Inc. leadership
- Christopher GerryPresident, General Counsel, Secretary & Director
- Anand ParikhCOO & Director
- Josiah CraverSenior Vice President of Finance, Principal Financial Officer & Principal Accounting Officer
- Anand ParikhCo-founder of Faeth Therapeutics and new Chief Operating Off
- Lora PikeVice President of Investor Relations & Communications
- Anand Kiran ParikhExecutive Officer
8 more named people on record for Sensei Biotherapeutics, Inc., with roles, board committees and tenure — see the full roster →
Hiring at Sensei Biotherapeutics, Inc.
Xcout recorded 16 job postings from Sensei Biotherapeutics, Inc. in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see Sensei Biotherapeutics, Inc.'s hiring signals →
Investors
Tech stack
Sensei Biotherapeutics, Inc. competitors
A few of Sensei Biotherapeutics, Inc.'s closest competitors — see the full list of competitors and alternatives →
Implicit Bioscience, Inc. is a biotechnology company founded in 2002 that focuses on the clinical development of novel immunotherapies and treatments for critical illnesses.
Lassen Therapeutics is a biotechnology research company based in San Diego, California, focused on developing novel, best-in-class biotherapeutics to treat patients with serious diseases.
BreStem Therapeutics, Inc. is a clinical-stage biotechnology company located in Raleigh, North Carolina, focused on developing novel therapeutics to fight various diseases.
OSE Immunotherapeutics is a clinical-stage biotechnology company that develops innovative immunotherapies for immune activation and regulation in immuno-oncology and immuno-inflammation. The company utilizes proprietary research platforms and a portfolio of clinical-stage assets to provide therapeutic options for patients.
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Sante Veritas Therapeutics Inc is a biotechnology company that develops FGL2-based diagnostic and therapeutic technologies. The company serves patients and researchers by targeting autoimmune diseases, transplant rejection, bacterial and viral infections, and cancer.
Get Sensei Biotherapeutics, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Sensei Biotherapeutics, Inc. in Xcout Intel
- 14 named people with titles, LinkedIn and board committees
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access